Search Tufts Medicine

Search Filters
Content type
medical-person
Need care for your condition?
Displaying 41 - 60 of 63
page
...
The ACGME- accredited hematopathology fellowship at Tufts Medical Center offers broad in-depth training in clinical hematology, hematopathology, flow cytometry, cytogenetics, immunopathology, coagulation and laboratory medicine.
Patient Stories
February 2, 2019
There was only one thing that was more important to Bob than receiving a kidney transplant. Seeing his son graduate. Tufts Medical Center's Kidney Transplant team made both happen.
page
...
The Anesthesiology Critical Care Medicine Fellowship Program at Tufts Medical Center is an ACGME accredited training program providing one year of comprehensive, multidisciplinary training in critical care medicine.
News
June 27, 2019
Meeting with heart transplant recipient at Tufts MC brings comfort, closure for donor family.
Articles
October 23, 2023
There are hundreds of thousands of people in the U.S. on organ transplant wait lists. Read Tufts Medical Center's perspective on what you can do to help.
Patient Stories
April 21, 2021
Jose was tested for COVID-19 after a few of his coworkers came down with the virus. At first, he felt fine, but then he had trouble breathing and was taken to the hospital. Soon he was in a coma and on a ventilator.
Patient Stories
April 6, 2019
Albert Plummer received the first heart transplant at Tufts Medical Center (Tufts MC), giving him 11 more years with his family doing the things he loved. He left a lasting legacy on the Tufts Medical Center CardioVascular Center.
page
...
Tufts Medical Center’s Neurosurgery Residency Program in Boston teaches bedside and operating room techniques to neurosurgery residents.
Patient Stories
April 21, 2021
Ruby was diagnosed with late-stage neuroblastoma, a type of cancer found in the small glands on top of the kidneys, when she was three. She is now 7 and playing on her swing set.
clinical trial
...

A Phase 2/3 Adaptive, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of VX-147 in Subjects Aged 18 Years and Older With APOL1-mediated Proteinuric Kidney Disease
department
The understanding of cancer is growing every day and our clinicians are making a significant impact on how the world researches, teaches and delivers care to improve quality and quantity of life.
department
Since our first class in 1893, the Department of Surgery has pioneered possibilities across the full spectrum of surgical illness. We're leading the way in surgical care, from minimally invasive techniques to transplant surgery.
clinical trial
...

This is a study of the prevalence of APOL1 alleles in adults who are of recent African ancestry or geographic origin. The study will enroll up to a total of approximately 2500 subjects into 2 groups. Group 1 includes subjects with FSGS, and Group 2 includes subjects with other forms of proteinuric nondiabetic CKD. No study drug will be administered.
clinical trial
...

The purpose of this Phase II trial is to see if R3R01 is safe in patients with Alport Syndrome and Focal Segmental Glomerulosclerosis. This will be done by evaluating how efficient R3R01 is in decreasing proteinuria levels. 

The study will consist of a screening period, a treatment period, and a follow-up period. If you qualify, you will receive the study drug R3R01 for 12 weeks. We will then follow up with you after for an additional 12 weeks.
department
The Division of Geographic Medicine + Infectious Diseases is an international center of excellence in infectious disease, inpatient and outpatient treatment, research, and infectious disease fellowship training.